Published in Genet Med on February 01, 2013
Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing. Genet Med (2013) 1.63
Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide. J Law Med Ethics (2015) 0.90
Funding considerations for the disclosure of genetic incidental findings in biobank research. Clin Genet (2013) 0.87
Rare disease research: Breaking the privacy barrier. Appl Transl Genom (2014) 0.79
Return of research results from genomic biobanks: cost matters. Genet Med (2012) 2.93
Return of results in genomic biobank research: ethics matters. Genet Med (2013) 1.20
Secondary variants and human subjects research. Genet Med (2013) 1.02
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med (2013) 22.73
International network of cancer genome projects. Nature (2010) 20.35
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med (2010) 13.57
Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics (2008) 12.10
Identifying personal genomes by surname inference. Science (2013) 10.79
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature (2012) 8.31
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet (2010) 6.74
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med (2012) 4.04
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Recommendations for returning genomic incidental findings? We need to talk! Genet Med (2013) 3.23
Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol (2006) 3.12
SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res (2007) 2.98
A typology of shared decision making, informed consent, and simple consent. Ann Intern Med (2004) 2.94
Return of research results from genomic biobanks: cost matters. Genet Med (2012) 2.93
Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility. Genome Res (2012) 2.76
Implications of disclosing individual results of clinical research. JAMA (2006) 2.75
Modern age pathology of pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 2.68
Induction of myeloid-derived suppressor cells by tumor exosomes. Int J Cancer (2009) 2.64
Newborn screening technology: proceed with caution. Pediatrics (2006) 2.54
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem (2007) 2.38
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood (2007) 2.35
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res (2009) 2.33
Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice. Arthritis Rheum (2011) 2.33
Practical implementation issues and challenges for biobanks in the return of individual research results. Genet Med (2012) 2.32
Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res (2007) 2.27
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin Chem (2007) 2.23
Informed consent in research to improve the number and quality of deceased donor organs. Crit Care Med (2011) 2.18
The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol (2012) 2.17
Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol (2007) 2.16
The legal risks of returning results of genomics research. Genet Med (2012) 2.15
Mandatory extended searches in all genome sequencing: "incidental findings," patient autonomy, and shared decision making. JAMA (2013) 2.06
Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res (2004) 2.02
Promoter hypermethylation profile of kidney cancer. Clin Cancer Res (2004) 2.02
CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest (2004) 2.01
Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res (2011) 1.98
Experiences and attitudes of genome investigators regarding return of individual genetic test results. Genet Med (2013) 1.97
Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experience. Genome Res (2011) 1.91
Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents. Clin Cancer Res (2002) 1.89
Antibody responses of variable lymphocyte receptors in the lamprey. Nat Immunol (2008) 1.87
Personalized genomic information: preparing for the future of genetic medicine. Nat Rev Genet (2010) 1.87
A functional anatomic defect of the cystic fibrosis airway. Am J Respir Crit Care Med (2014) 1.85
Exosomes and cancer: a newly described pathway of immune suppression. Clin Cancer Res (2011) 1.83
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma. Cancer (2004) 1.78
Thymus exosomes-like particles induce regulatory T cells. J Immunol (2008) 1.73
The futility of genomic counseling: essential role of electronic health records. Genome Med (2009) 1.73
Multiple gene expression analyses in paraffin-embedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn (2006) 1.70
Expression of sperm protein 17 (Sp17) in ovarian cancer. Int J Cancer (2004) 1.70
LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem (2003) 1.66
Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res (2007) 1.66
Identifiability in biobanks: models, measures, and mitigation strategies. Hum Genet (2011) 1.66
Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. Clin Cancer Res (2003) 1.65
Principal investigator views of the IRB system. Int J Med Sci (2008) 1.63
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine. Trials (2014) 1.62
Openness of patients' reporting with use of electronic records: psychiatric clinicians' views. J Am Med Inform Assoc (2010) 1.59
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator. Clin Cancer Res (2004) 1.58
Shaping patients' decisions. Chest (2011) 1.58
Method for quantitative study of airway functional microanatomy using micro-optical coherence tomography. PLoS One (2013) 1.56
14-3-3σ (sigma) regulates proliferation and differentiation of multipotent p63-positive cells isolated from human breastmilk. Cell Cycle (2011) 1.51
The ethical use of existing samples for genome research. Genet Med (2009) 1.48
Confronting real time ethical, legal, and social issues in the Electronic Medical Records and Genomics (eMERGE) Consortium. Genet Med (2010) 1.47
"Human non-subjects research": privacy and compliance. Am J Bioeth (2010) 1.44
Direct-to-consumer genetic testing: perceptions, problems, and policy responses. Annu Rev Med (2011) 1.43
Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes (2009) 1.42
A framework for biobank sustainability. Biopreserv Biobank (2014) 1.41
MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis (2011) 1.39
Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol (2006) 1.39
Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections. J Histochem Cytochem (2009) 1.38
Don't throw the baby out with the bathwater: enabling a bottom-up approach in genome-wide association studies. Genome Res (2008) 1.37
Incidental copy-number variants identified by routine genome testing in a clinical population. Genet Med (2012) 1.33
Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology (2009) 1.33
Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J Immunol (2007) 1.30
Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res (2005) 1.30
Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res (2004) 1.29
Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation. Int J Radiat Oncol Biol Phys (2002) 1.28
Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer. Mol Cell Biol (2009) 1.28
Bax expression is a candidate prognostic and predictive marker of colorectal cancer. J Gastrointest Oncol (2010) 1.24
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology (2008) 1.23
Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma. Laryngoscope (2003) 1.22
A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases. Clin Cancer Res (2010) 1.21
Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors. Oncogene (2005) 1.21
The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology (2004) 1.21
Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology (2008) 1.20